确认您不是来自美国或菲律宾

在此声明,本人明确声明并确认:
  • 我不是美国公民或居民
  • 我不是菲律宾居民
  • 本人没有直接或间接拥有美国居民10%以上的股份/投票权/权益,和/或没有通过其他方式控制美国公民或居民。
  • 本人没有直接或间接的美国公民或居民10%以上的股份/投票权/权益的所有权,和/或受美国公民或居民其他任何方式行使的控制。
  • 根据FATCA 1504(a)对附属关系的定义,本人与美国公民或居民没有任何附属关系。
  • 我知道做出虚假声明所需付的责任。
就本声明而言,所有美国附属国家和地区均等同于美国的主要领土。本人承诺保护Octa Markets Incorporated及其董事和高级职员免受因违反本声明而产生或与之相关的任何索赔。
我们致力于保护您的隐私和您个人信息的安全。我们只收集电子邮件,以提供有关我们产品和服务的特别优惠和重要信息。通过提交您的电子邮件地址,您同意接收我们的此类信件。如果您想取消订阅或有任何问题或疑虑,请联系我们的客户支持。
Back

NZD/USD refreshes multi-month top above 0.6900 amid risk-on markets

  • NZD/USD refreshes intraday high, bulls eye 20-month high flashed last week.
  • NZ Trade Minister O'Connor says strong NZD is always a concern.
  • Vaccine news backs the buyers even as virus woes bother US states.

NZD/USD gains 0.10% intraday, to currently around 0.6915, after refreshing the highest level since March 26, 2019 during Tuesday’s Asian session. In doing so, the kiwi pair offered a knee-jerk reaction to the trade-negative comments from New Zealand’s Trade Minister Damien O'Connor. The reason could be traced from the market’s optimism backed by the coronavirus (COVID-19) vaccine news.

Vaccine optimism dominates…

New Zealand Trade Minister O’Connor conveyed worries for the recently surging New Zealand (NZD), due to the economy’s trade-oriented nature. Even so, nothing specific could be found for the kiwi dollar and hence traders concentrated on the vaccine hopes for immediate direction.

Read: NZ Trade Minister O'Connor: Strong NZD is always a concern

Not only Moderna’s 94.5% effective vaccine, as per the latest trial results but news that Johnson and Johnson also begin the late-stage trials on its two-dose vaccine favor the market’s trading sentiment off-late. It should also be noted that Pfizer-BioNtech earlier rolled out a 90% success rate for their vaccine trials and boosted hopes that the world will be able to conquer the covid.

Amid these plays, New Zealand’s NZX 50 prints mild losses while shares from Japan and Australia print gains by press time. Further, the US stock futures also struggle for a clear direction as the COVID-19 resurgence in America put brakes on the recovery plans.

Looking forward, risk catalysts will be the key amid a lack of major data/events from New Zealand. Against this backdrop, the Australia and New Zealand Banking Group (ANZ) said,

“Kiwi is higher overnight, with risk appetite surging after more positive vaccine news, which saw US equities jump to near-record highs. Vaccine deployment won’t all be plain sailing, and things will still feel pretty tough as we go into 2021 given the lags in achieving inoculation and immunity, the still raging global pandemic, and the more pressing near-term issue of how NZ copes with a summer without tourists and a reversal in the fiscal impulse, all of which we need to overcome before a vaccine becomes widely available. But for now it’s sentiment driving markets and in that environment the risk is NZD goes higher.”

Technical analysis

The early 2019 top near 0.6940/45 lures NZD/USD buyers, for now. On the contrary, the monthly support line near 0.6860 offers immediate support.

 

RBA Minutes: Ready to provide yet more policy stimulus

The Reserve Bank of Australia's Minutes has sown that the central bank is ready to provide yet more policy stimulus if needed after cutting rates to r
了解更多 Previous

AUD/USD challenges monthly top above 0.7300 after RBA minutes

AUD/USD rises to the fresh one-week high of 0.7330, currently up 0.10% intraday around 0.7327, amid Tuesday’s Asian session. The pair recently benefit
了解更多 Next